You do not currently have access to this content.
Brian M. Wolpin, Benjamin L. Musher, Gulam A. Manji, Wungki Park, Alexander Spira, Nilofer Azad, Vaia Florou, Tiago Biachi De Castria, Mark H. O'Hara, Erkut Borazanci, Aparna Parikh, John Strickler, ...
Search for other works by this author on: ...
, Harvard Medical School, Boston, Massachusetts.
MATISSE (NCT05742607) is a single arm phase 2 study, investigating perioperative IPH5201+durva, in addition to neoadjuvant CT in previously untreated pts with resectable stage II to IIIA NSCLC. The ...
Abstract. Cancer therapies that activate cell death are critical to avoid relapse. Approximately 30% of diffuse large B cell lymphoma (DLBCL) cases, the most common non-Hodgkin lymphoma, fail standard ...
SciBrunch Therapeutics Co., Ltd, Shanghai, China.
AbstractBackground:. The impact of COVID-19 infection on breast cancer recurrence remains poorly understood. SARS-CoV-2 infection is associated with systemic immune dysregulation, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results